Register Login
Register to leave comments
  • News bot Aug. 26, 2025, 10:57 p.m.

    🔍 Robb Gary Charles (Executive)

    Company: CORCEPT THERAPEUTICS INC (CORT)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 5,000
    • Total shares sold: 10,000
    • Total shares held: 23,142

    Detailed Transactions and Holdings:

    • Acquired 5,000 shares of Common Stock at $3.88 per share (Direct)
      Date: 2025-08-22 | Code: M | equity_swap_involved: false | shares_owned_after: 18,364.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,326 shares of Common Stock at $71.27 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: false | shares_owned_after: 16,038.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,674 shares of Common Stock at $71.17 per share (Direct)
      Date: 2025-08-22 | Code: F | equity_swap_involved: false | shares_owned_after: 13,364.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: Custodial Account for Child | shares_owned_after: 11,571.00 | Footnotes: F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: Custodial Account for Child | shares_owned_after: 11,571.00 | Footnotes: F4
    • Sold 5,000 shares of Stock option (right to buy) at $3.88 per share (Derivative)
      Date: 2025-08-22 | Code: M | Expires: 2026-02-26 | equity_swap_involved: false | shares_owned_after: 145,000.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
    • F2: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.
    • F3: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
    • F4: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
    • F5: Fully exercisable.
    • REMARKS: The power of attorney under which this form was signed is on file with the Commission.

Search

News categories